← FDA Drug Approvals (Drugs@FDA)

XARELTO

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2011-11-04

Drug application

FDA Application #

NDA202439

Application type

New Drug Application

Brand name

XARELTO

Generic name

Rivaroxaban

Active ingredients

RIVAROXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

JANSSEN PHARMS

First approval

2011-11-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown